Dova Pharmaceuticals Reports Second Quarter 2019 Operating and Financial Results

NEXT STORY
XOMA Reports Second Quarter 2019 Royalty Asset Portfolio Highlights and Financial Results
PREV STORY
TCR2 Therapeutics Deepens Manufacturing and Immuno-Oncology Expertise with Key Hires
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Helsinn Therapeutics (U.S.) Inc. becomes the exclusive distributor of ALOXI® (palonosetron HCI) in the U.S.

Helsinn Therapeutics (U.S.) Inc. becomes the exclusive distributor of ALOXI® (palonosetron HCI) in the ...

author_avatar
NASDAQ Market News

Delcath Announces Another DSMB Recommendation for Phase 3 Focus Trial

FOCUS trial to continue without modificationNEW YORK, May 03, 2018 (GLOBE NEWSWIRE) -- Delcath ...

author_avatar
NASDAQ Market News

Celldex Reports Fourth Quarter and Year-End 2015 Results

HAMPTON, N.J., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported ...

author_avatar
NASDAQ Market News